Communicable disease threats report, 10-16 March 2019, Week 11
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 10-16 March 2019 and includes updates on poliomyelitis, Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola virus disease, influenza, Neisseria gonorrhoeae and Rift Valley fever.
Creutzfeldt−Jakob disease - Annual Epidemiological Report for 2016
Two cases of variant Creutzfeldt−Jakob disease (vCJD) were identified in the EU/EEA in 2016: one probable case from Italy and one confirmed case from the UK.
Operational tool on rapid risk assessment methodology - ECDC 2019
Rapid risk assessments (RRA) are undertaken in the initial stages of an event or incident of potential public health concern while more comprehensive risk assessments, which often include the conduct of full systematic reviews, are produced at a later stage of an event, usually when more time and information are available.
West Nile virus infection - Annual Epidemiological Report for 2016
For 2016, seven EU/EEA Member States reported 238 West Nile virus (WNV) infections, of which 224 (94%) were locally acquired and 14 were travel-related.
Influenza virus characterisation, February 2019
This is the fourth report for the 2018-19 influenza season.
Rapid outbreak assessment: Multi-country outbreak of Salmonella Poona infections linked to consumption of infant formula
This document provides an assessment of the cross-border public health risk related to the outbreak of Salmonella Poona infections in infants and young children linked to consumption of infant formula.
Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico
This outbreak of Verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) surgical site infections, related to invasive procedures performed in healthcare facilities in Tijuana, Baja California, Mexico, highlights the risks associated with medical tourism for patients and healthcare systems in the countries of origin.